⚡
Pain Medicine
What the Latest Research Reveals
Data last updated: 41 studies cited
How this page is produced
Generated by the ModernDoc Research Monitor from peer-reviewed literature. Every statistic is automatically checked against its cited source and screened for retractions before it is published. This page is AI-generated and has not yet been reviewed by a clinician — it is not medical advice. Read how we build and check these pages.
30-40%
of long COVID patients meet fibromyalgia criteria
— with objective small fiber neuropathy in many cases
KEY FINDINGS
Fibromyalgia Diagnosis
+133%
95% CI: HR 2.33 (95% CI: 1.86-2.92)
Source [6]
Headache Disorder
+89%
95% CI: HR 1.89 (95% CI: 1.54-2.32)
Source [19]
Neuropathy Diagnosis
+67%
95% CI: HR 1.67 (95% CI: 1.38-2.02)
Source [23]
Chronic Pain Diagnosis
+54%
95% CI: HR 1.54 (95% CI: 1.42-1.67)
Source [6]
THE TIMELINE
Acute Phase
0-4 weeks
Subacute Phase
4-12 weeks
Chronic Phase
3-12 months
Long-Term
>12 months
Acute Phase
0-4 weeks
30-50% myalgia, 15-25% arthralgia
Key Event
Myalgia and arthralgia peak
Persistent Pain at 12 Months
COVID-19RR 1.42
InfluenzaBaseline
Source: Comparative cohort studies (RR 1.42, 95% CI: 1.21-1.67)
Cumulative Pain Risk with Reinfection
1 infection+12-15%
2 infections+18-22%
3+ infections+22-28%
“Each infection adds to neuroinflammatory and pain burden”
THE HOPEFUL HORIZON
- Vaccination reduces chronic pain risk by 30-50% (OR 0.5-0.7)[8]
- 50-60% of patients show gradual improvement over 6-12 months[1]
- Small fiber neuropathy is a treatable cause of chronic pain[11]
- Low-dose naltrexone shows emerging promise for neuroinflammation[30]
SOURCES
- [1]Fernandez-de-las-Penas C, et al. Prevalence of musculoskeletal post-COVID pain: A systematic review and meta-analysis. Pain. 2024;165(4):735-751. DOI (opens in new tab)
- [2]Fernandez-de-las-Penas C, et al. Long-COVID symptoms in individuals infected with different SARS-CoV-2 variants: A systematic review. Viruses. 2023;15(3):746. DOI (opens in new tab)
- [3]Fernandez-de-las-Penas C, et al. Headache as a COVID-19 symptom: A meta-analysis. J Headache Pain. 2023;24(1):15. DOI (opens in new tab)
- [4]Lopez-Leon S, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11:16144. DOI (opens in new tab)
- [5]Alkodaymi MS, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: A systematic review and meta-analysis. Clin Microbiol Infect. 2022;28(5):657-666. DOI (opens in new tab)
See a problem with the Pain Medicine research summary?
Send a source correction or freshness concern. We cannot provide personal medical advice through this site.
Report a correctionSHARE THIS INFORMATION
Share with someone who needs to know